Skip to Content
by Bill Snyder | Tuesday, Jul. 5, 2016, 11:22 AM
Researchers at Vanderbilt University Medical Center (VUMC) and Duke Clinical Research Institute (DCRI) have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.
The seven-year, $26.5 million grant for a joint Trial Innovation Center (TIC) is supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The center will be a key component of the Trial Innovation Network, which is the newest part of the Clinical and Translational Science Award (CTSA) Program.
Danny Benjamin, M.D., MPH, Ph.D., faculty associate director of the DCRI, and Gordon Bernard, M.D., director of the Vanderbilt Institute for Clinical and Translational Research (VICTR), are the grant’s principal investigators.
“The DCRI and Vanderbilt partnership is a perfect fit for the TIC,” said Benjamin. “The academic research organization model at the DCRI and Vanderbilt’s informatics and central institutional review board model are poised to immediately contribute to the NIH’s vision of high-functioning networks for clinical research.”
“We are excited about the opportunity to be on the ground floor of building a new infrastructure for the efficient conduct of high-quality clinical research that has a major impact on human health,” said Bernard, executive vice president for research at VUMC.
The Duke-Vanderbilt TIC will have three components:
All stages will be assisted by an Innovations Core, led by VICTR’s Paul Harris, Ph.D., and the DCRI’s Brian McCourt, which will create innovative solutions to streamline and expedite interactions with the clinical trial sites.
The Trial Innovation Network will include other TICs, as well as Recruitment Innovation Centers (RICs), which will study ways to engage more volunteers in clinical research. Both programs will leverage the expertise and resources of the NCATS CTSA Program.
About the Duke Clinical Research Institute
The DCRI is the largest academic research organization in the world, with a mission to develop and share knowledge that improves the care of patients through innovative clinical research. The DCRI conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.
About the Vanderbilt Institute for Clinical and Translational Research
VICTR has pioneered numerous research innovations including REDCap, a Web application that helps academic scientists around the globe collect and manage their research data; the Accelerated Clinical Trial Agreement, which streamlines clinical contracting for multisite studies. Other innovations include a technical system which facilitates and provides infrastructure support for a single institutional review board review system; and ResearchMatch, a nationwide online research volunteer recruitment and engagement service. VUMC also is the coordinating center for eMERGE (Electronic Medical Records and Genomics Network), funded by the National Human Genome Research Institute, which combines DNA biorepositories with electronic medical record systems for large-scale, high-throughput genetic research.
Bill Snyder, (615) 322-4747
There are lots of ways to keep up with Vanderbilt. Choose your preferred method: